Genomic and tumor biological aspects of the anticancer nicotinamide phosphoribosyltransferase inhibitor FK866 in resistant human colorectal cancer cells-Reference-Cited by-同舟云学术

Genomic and tumor biological aspects of the anticancer nicotinamide phosphoribosyltransferase inhibitor FK866 in resistant human colorectal cancer cells

Published:2019-12 Issue:6 Volume:111 Page:1889-1895
ISSN:0888-7543
Container-title:Genomics
language:en
Short-container-title:Genomics

Author:

Ogino Yoko,Sato Akira^ORCID,Uchiumi Fumiaki,Tanuma Sei-ichi

Funder

Tokyo University of Science

Enago

Research Education Fund

Publisher

Elsevier BV

Subject

Genetics

Reference28 articles.

1. Drug resistance in cancer: an overview;Housman;Cancers,2014

2. Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors;Galli;J. Med. Chem.,2013

3. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer;Sampath;Pharmacol. Ther.,2015

4. NAD+ salvage pathway in cancer metabolism and therapy;Kennedy;Pharmacol. Res.,2016

5. New Insights into the Roles of NAD+-Poly(ADP-ribose) Metabolism and Poly(ADP-ribose) Glycohydrolase;Tanuma;Curr. Protein Pept. Sci.,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial rewiring drives metabolic adaptation to NAD(H) shortage in triple negative breast cancer cells;Neoplasia;2023-07

2. Relationship between anticancer sensitivities and cellular respiration properties in 5‐fluorouracil‐resistant HCT116 human colorectal cancer cells;FEBS Open Bio;2023-04-19

3. Genomic and biological aspects of resistance to selective poly( ADP ‐ribose) glycohydrolase inhibitor PDD00017273 in human colorectal cancer cells;Cancer Reports;2022-08-26

4. A Nicotinamide Phosphoribosyltransferase Inhibitor, FK866, Suppresses the Growth of Anaplastic Meningiomas and Inhibits Immune Checkpoint Expression by Regulating STAT1;Frontiers in Oncology;2022-04-20

5. Trapping of 5-Fluorodeoxyuridine Monophosphate by Thymidylate Synthase Confers Resistance to 5-Fluorouracil;ACS Omega;2022-02-09